A Prospective, Multicenter, Open-Label, Non-Randomized, Controlled Pivotal Study to Evaluate the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix in Implant-Based Two Stage Prepectoral Breast Reconstruction Post-Mastectomy
AbbVie
Summary
The purpose of this study is to evaluate the safety and effectiveness of ARTIA in adult participants undergoing immediate, two-stage, implant-based breast reconstruction post-mastectomy.
Eligibility
- Age range
- 18+ years
- Sex
- Female
- Healthy volunteers
- No
Inclusion Criteria: * Participants who will undergo unilateral or bilateral mastectomy upon enrollment. * Participants who are willing and able to undergo immediate pre-pectoral two-stage breast reconstruction with ARTIA or without ADM. Exclusion Criteria: * Has an existing carcinoma of the breast without planned mastectomy or residual gross local tumor of the breast after mastectomy. * Has any disease which is clinically known to impact wound healing ability, such as uncontrolled diabetes or history of compromised wound healing.
Interventions
- DeviceARTIA Reconstructive Tissue Matrix
Surgical Implant
- OtherNo Intervention
No ADM
Locations (21)
- Cedars-Sinai Medical Center /ID# 268326Los Angeles, California
- UC Irvine Medical Center /ID# 267428Orange, California
- Stanford University Medical Center CTRU - 800 Welch Road /ID# 264196Palo Alto, California
- South Bay Plastic Surgeons /ID# 264192Torrance, California
- University Of Colorado - Anschutz Medical Campus /ID# 268627Aurora, Colorado
- University of Florida College of Medicine /ID# 267485Gainesville, Florida